Article Details

Pivotal Odronextamab (CD20xCD3) Phase 2 Data in Patients with Relapsed ... - PR Newswire

Retrieved on: 2022-12-11 17:03:54

Tags for this article:

Click the tags to see associated articles and topics

Pivotal Odronextamab (CD20xCD3) Phase 2 Data in Patients with Relapsed ... - PR Newswire. View article details on hiswai:

Excerpt

Regeneron uses its media and investor relations website and social media outlets to publish important information about the Company, ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up